Skip to content

Hispanic Men Building Respect Education and Safety/ HoMBRES Manteniendo Respeto, Educacion y Seguridad.

Hispanic Men Building Respect Education and Safety (Family Men) - Substudy Under Center for Latino Research Opportunities (CLaRO)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03730987
Acronym
HoMBRES
Enrollment
244
Registered
2018-11-05
Start date
2019-04-19
Completion date
2021-07-30
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Domestic Violence, HIV/AIDS, Substance Abuse

Keywords

Family Violence, Hispanic/Latino, Health Disparities, Migrant farmworkers

Brief summary

The overall objective of this project is to adapt and enhance HoMBReS (Hispanic Men Building Respect, Education, and Safety within Families /Hombres Manteniendo Respeto, Educacion y Seguridad de Familia), a Center for Disease Control (CDC)-identified best-evidence HIV behavioral intervention designed to reduce substance abuse, family violence, and HIV/AIDS (SAVA) among sexually active heterosexual Latino seasonal farmworkers (LSFWs) in rural areas.

Detailed description

The HoMBRES de Familia project study (HoMBRES) examined the efficacy of a culturally adapted group intervention program with fathers from a seasonal farm working community and an Urban community in South Florida. The HoMBRES intervention study adapted and tested the efficacy of an intervention that can be adopted, implemented, and sustained with Latino fathers who live or work in the farm industry, construction, services, self employed or any other work industry in the semi-rural areas and urban areas of Miami Dade County. The HoMBRES intervention seeked to reduce risk for the SAVA (Substance Abuse, Violence, and HIV/AIDS infection) syndemic among this group of men and their adolescent sons. The intervention HoMBRES consisted of four sessions remotely facilitated via a well-tested video platform accessible by a link sent to the participants' telephone, computer, tablet or IPad (approximately 1.5 hours each session). Staff scheduled the times when participants will watch the videotaped sessions in order to be available for their questions. Intervention videos were followed up with a telephone call to discuss presentation and respond to any questions participants may have had about the sessions and clarify (if needed) the material covered in the videos via telephone. Video sessions were completed within two weeks time period. Participants in the control group received one single video on diabetes prevention. Both groups were followed up six months post baseline interview.

Interventions

BEHAVIORALHoMBReS intervention

Adapted intervention based on social cognitive theory and empowerment education that aims to reduce risky sexual behaviors, substance abuse and HIV among recently immigrated rural and urban men.

The brief intervention, is a parent-based intervention to teach parents effective strategies proven to reduce adolescent sexual risk behavior. The intervention specifically targets the parent (not the adolescent) to: promote communication skills, build parent-adolescent relationships, develop effective monitoring strategies, reduce alcohol use, risky sexual behaviors and prepare them to teach adolescents assertiveness and substance abuse refusal skills.

Session content will focus on the importance of physical activity, healthy eating and maintaining a healthy weight.

Sponsors

University of Miami
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* male * adults (age 18 or above) * living in semirural and urban areas of Miami Dade * Latino * understand and speaks Spanish * has an eligible son ( 11-17 years old)

Exclusion criteria

* father does not provide consent and permission for his son * son does not provide assent

Design outcomes

Primary

MeasureTime frameDescription
Number of Participant Fathers Self-reporting Engagement in Risky Sexual BehaviorsAt Baseline, at 6 months follow upThe number of participants that responded 'yes' to any of the following questions on the PhenX Toolkit Sexual Risk Behavior will be reported as self-reporting engagement in risky sexual behaviors; a) engaging in unprotected sexual encounters, b) more than one partner, c) anal sex with man in the last 6 months.
The Number of Participant Fathers Self-reporting Experiences of Intra-partner ViolenceAt Baseline, at 6 monthsAs measured using the PhenX Toolkit Exposures to Violence self-reported instrument. The variable was recoded using four categories: (1) "Your partner physically hurt you; (2) Insult or talk down to you; (3) Threaten you with harm; (4) Scream or curse at you. The responses are scored on a Likert-type scale 1=Never, 2=Rarely, 3=Sometimes, 4=Frequently, and 5=Always. The number of participants reporting 3 or higher on the Likert scale to any of the four categories, will be recorded as experiencing intra-partner violence.
The Number of Days Participant Fathers Reported Drinking in the Past 90 Days.At Baseline, at 6 monthsThe number of days participant reported drinking in the past 90 days using the Time-Line Followback self-reported questionnaire.
HIV Knowledge as Measured by the Brief HIV Knowledge QuestionnaireAt Baseline, at 6 monthsAs measured by the Brief HIV Knowledge Questionnaire. The proportion of correct answers will be reported (ranging from 0 to 1), with a score closer to 1 indicating higher HIV knowledge.
HIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV ScaleAt Baseline, at 6 monthsSelf-Efficacy for Sexually Transmitted Infection (STI) and HIV Scale is a 9-item scale measuring the level of confidence in the ability to prevent STI and HIV infection. The measure uses a 5-point Likert scale (1=not sure at all to 5= completely sure). Total score ranges 9 to 45, with a higher score indicating a higher level of HIV self-efficacy.
The Number of Drinks Per Day Over the Past 90 Days.At Baseline, at 6 monthsThe number of drinks per day over the past 90 days using the Timeline Followback.

Secondary

MeasureTime frameDescription
Level of Self-reported Communication With Son as Measured by the Parental Practicing ScaleAt Baseline, At 6 monthsThe self-reported Parenting Practices Scale has a total score ranging from 1-5, with higher scores indicating higher levels of parental monitoring among the fathers. The adolescents responded to the son's version of the scale.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORVictoria Behar-Zusman, PhD

University of Miami

Participant flow

Recruitment details

Only the father received the study intervention and completed the questionnaires that were included in the data for the primary and secondary outcomes. The adolescent received no intervention.

Participants by arm

ArmCount
HoMBRES Intervention Group - Father
Participants in the intervention study will receive the adapted HoMBRES intervention which consisted of three participatory lectures and discussion session with the facilitator. Only fathers are included in this group.
61
Diabetes Prevention Intervention Group - Father
Participants in the Diabetes group received a single participatory lecture on diabetes prevention and discussion session with the facilitator. Only fathers are included in this group.
61
HoMBRES Intervention Group - Adolescent
Adolescent from the did not receive any intervention. They only participated in baseline and six months follow up.
61
Diabetes Prevention Intervention Group - Adolescent
Adolescent did not receive any intervention. They only participated in baseline and six months follow up.
61
Total244

Baseline characteristics

CharacteristicHoMBRES Intervention Group - FatherDiabetes Prevention Intervention Group - FatherHoMBRES Intervention Group - AdolescentDiabetes Prevention Intervention Group - AdolescentTotal
Age, Continuous42.5 years44.4 years13.9 years13.7 years28.6 years
Ethnicity (NIH/OMB)
Hispanic or Latino
61 Participants61 Participants61 Participants61 Participants244 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
9 Participants5 Participants5 Participants8 Participants27 Participants
Race (NIH/OMB)
More than one race
18 Participants10 Participants5 Participants8 Participants41 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants0 Participants1 Participants2 Participants
Race (NIH/OMB)
White
33 Participants46 Participants51 Participants44 Participants174 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
61 Participants61 Participants61 Participants61 Participants244 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 610 / 610 / 610 / 61
other
Total, other adverse events
0 / 610 / 610 / 610 / 61
serious
Total, serious adverse events
0 / 610 / 610 / 610 / 61

Outcome results

Primary

HIV Knowledge as Measured by the Brief HIV Knowledge Questionnaire

As measured by the Brief HIV Knowledge Questionnaire. The proportion of correct answers will be reported (ranging from 0 to 1), with a score closer to 1 indicating higher HIV knowledge.

Time frame: At Baseline, at 6 months

Population: Two participants did not complete the 6-months follow up interview in the HoMBRES group. Only the father received the study intervention and completed the questionnaires that were included in the data for the primary outcomes and adolescents were only included in the secondary outcomes. The adolescent received no intervention and were not included in the primary outcome dataset.

ArmMeasureGroupValue (MEAN)Dispersion
HoMBRES Intervention Group - FatherHIV Knowledge as Measured by the Brief HIV Knowledge QuestionnaireBaseline0.65 units on a scaleStandard Deviation 0.18
HoMBRES Intervention Group - FatherHIV Knowledge as Measured by the Brief HIV Knowledge Questionnaire6-months follow up0.81 units on a scaleStandard Deviation 0.19
Diabetes Prevention Intervention Group - FatherHIV Knowledge as Measured by the Brief HIV Knowledge QuestionnaireBaseline0.65 units on a scaleStandard Deviation 0.21
Diabetes Prevention Intervention Group - FatherHIV Knowledge as Measured by the Brief HIV Knowledge Questionnaire6-months follow up0.69 units on a scaleStandard Deviation 0.19
Primary

HIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV Scale

Self-Efficacy for Sexually Transmitted Infection (STI) and HIV Scale is a 9-item scale measuring the level of confidence in the ability to prevent STI and HIV infection. The measure uses a 5-point Likert scale (1=not sure at all to 5= completely sure). Total score ranges 9 to 45, with a higher score indicating a higher level of HIV self-efficacy.

Time frame: At Baseline, at 6 months

Population: Two participants did not complete the 6-months follow up interview in the HoMBRES group. Only the father received the study intervention and completed the questionnaires that were included in the data for the primary and secondary outcomes. The adolescent received no intervention and were not included in the dataset.

ArmMeasureGroupValue (MEAN)Dispersion
HoMBRES Intervention Group - FatherHIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV ScaleBaseline38.30 score on a scaleStandard Deviation 5.1
HoMBRES Intervention Group - FatherHIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV Scale6 months follow up40.20 score on a scaleStandard Deviation 3.7
Diabetes Prevention Intervention Group - FatherHIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV ScaleBaseline38.80 score on a scaleStandard Deviation 6.1
Diabetes Prevention Intervention Group - FatherHIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV Scale6 months follow up38.50 score on a scaleStandard Deviation 5.4
Primary

Number of Participant Fathers Self-reporting Engagement in Risky Sexual Behaviors

The number of participants that responded 'yes' to any of the following questions on the PhenX Toolkit Sexual Risk Behavior will be reported as self-reporting engagement in risky sexual behaviors; a) engaging in unprotected sexual encounters, b) more than one partner, c) anal sex with man in the last 6 months.

Time frame: At Baseline, at 6 months follow up

Population: Not all participants completed the questions required. Only the father received the study intervention and completed the questionnaires that were included in the data for the primary and secondary outcomes. The adolescent received no intervention and were not included in the dataset.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
HoMBRES Intervention Group - FatherNumber of Participant Fathers Self-reporting Engagement in Risky Sexual BehaviorsBaseline42 Participants
HoMBRES Intervention Group - FatherNumber of Participant Fathers Self-reporting Engagement in Risky Sexual Behaviors6 months follow up38 Participants
Diabetes Prevention Intervention Group - FatherNumber of Participant Fathers Self-reporting Engagement in Risky Sexual BehaviorsBaseline38 Participants
Diabetes Prevention Intervention Group - FatherNumber of Participant Fathers Self-reporting Engagement in Risky Sexual Behaviors6 months follow up53 Participants
Primary

The Number of Days Participant Fathers Reported Drinking in the Past 90 Days.

The number of days participant reported drinking in the past 90 days using the Time-Line Followback self-reported questionnaire.

Time frame: At Baseline, at 6 months

Population: Two participants did not complete the 6-months follow up interview in the HoMBRES group. Only the father received the study intervention and completed the questionnaires that were included in the data for the primary and secondary outcomes. The adolescent received no intervention and were not included in the dataset.

ArmMeasureGroupValue (MEAN)Dispersion
HoMBRES Intervention Group - FatherThe Number of Days Participant Fathers Reported Drinking in the Past 90 Days.Baseline8.59 daysStandard Deviation 15.26
HoMBRES Intervention Group - FatherThe Number of Days Participant Fathers Reported Drinking in the Past 90 Days.6 months follow up11.08 daysStandard Deviation 20.2
Diabetes Prevention Intervention Group - FatherThe Number of Days Participant Fathers Reported Drinking in the Past 90 Days.Baseline6.72 daysStandard Deviation 11.98
Diabetes Prevention Intervention Group - FatherThe Number of Days Participant Fathers Reported Drinking in the Past 90 Days.6 months follow up8.48 daysStandard Deviation 14.37
Primary

The Number of Drinks Per Day Over the Past 90 Days.

The number of drinks per day over the past 90 days using the Timeline Followback.

Time frame: At Baseline, at 6 months

Population: Two participants did not complete the 6-months follow up interview in the HoMBRES group. Only the father received the study intervention and completed the questionnaires that were included in the data for the primary and secondary outcomes. The adolescent received no intervention and were not included in the dataset.

ArmMeasureGroupValue (MEAN)Dispersion
HoMBRES Intervention Group - FatherThe Number of Drinks Per Day Over the Past 90 Days.Baseline2.82 drinks per dayStandard Deviation 3.15
HoMBRES Intervention Group - FatherThe Number of Drinks Per Day Over the Past 90 Days.6 months follow up2.89 drinks per dayStandard Deviation 3.23
Diabetes Prevention Intervention Group - FatherThe Number of Drinks Per Day Over the Past 90 Days.Baseline2.35 drinks per dayStandard Deviation 2.43
Diabetes Prevention Intervention Group - FatherThe Number of Drinks Per Day Over the Past 90 Days.6 months follow up3.06 drinks per dayStandard Deviation 3.98
Primary

The Number of Participant Fathers Self-reporting Experiences of Intra-partner Violence

As measured using the PhenX Toolkit Exposures to Violence self-reported instrument. The variable was recoded using four categories: (1) Your partner physically hurt you; (2) Insult or talk down to you; (3) Threaten you with harm; (4) Scream or curse at you. The responses are scored on a Likert-type scale 1=Never, 2=Rarely, 3=Sometimes, 4=Frequently, and 5=Always. The number of participants reporting 3 or higher on the Likert scale to any of the four categories, will be recorded as experiencing intra-partner violence.

Time frame: At Baseline, at 6 months

Population: Two participants did not complete the 6-months follow up interview in the HoMBRES group. Only the father received the study intervention and completed the questionnaires that were included in the data for the primary and secondary outcomes. The adolescent received no intervention and were not included in the dataset.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
HoMBRES Intervention Group - FatherThe Number of Participant Fathers Self-reporting Experiences of Intra-partner ViolenceBaseline10 Participants
HoMBRES Intervention Group - FatherThe Number of Participant Fathers Self-reporting Experiences of Intra-partner Violence6 months follow up10 Participants
Diabetes Prevention Intervention Group - FatherThe Number of Participant Fathers Self-reporting Experiences of Intra-partner ViolenceBaseline9 Participants
Diabetes Prevention Intervention Group - FatherThe Number of Participant Fathers Self-reporting Experiences of Intra-partner Violence6 months follow up5 Participants
Secondary

Level of Self-reported Communication With Son as Measured by the Parental Practicing Scale

The self-reported Parenting Practices Scale has a total score ranging from 1-5, with higher scores indicating higher levels of parental monitoring among the fathers. The adolescents responded to the son's version of the scale.

Time frame: At Baseline, At 6 months

Population: Two participants did not complete the 6-months follow up interview in the HoMBRES group. Only the father received the study intervention and completed the questionnaires that were included in the data for the primary and secondary outcomes. The adolescent did not receive any interventions and were not included in the dataset.

ArmMeasureGroupValue (MEAN)Dispersion
HoMBRES Intervention Group - FatherLevel of Self-reported Communication With Son as Measured by the Parental Practicing ScaleBaseline4.1 score on a scaleStandard Deviation 0.8
HoMBRES Intervention Group - FatherLevel of Self-reported Communication With Son as Measured by the Parental Practicing Scale6 months follow up4.2 score on a scaleStandard Deviation 0.6
Diabetes Prevention Intervention Group - FatherLevel of Self-reported Communication With Son as Measured by the Parental Practicing Scale6 months follow up4.4 score on a scaleStandard Deviation 0.6
Diabetes Prevention Intervention Group - FatherLevel of Self-reported Communication With Son as Measured by the Parental Practicing ScaleBaseline4.3 score on a scaleStandard Deviation 0.6
HoMBRES Intervention Group - AdolescentLevel of Self-reported Communication With Son as Measured by the Parental Practicing ScaleBaseline3.41 score on a scaleStandard Deviation 0.92
HoMBRES Intervention Group - AdolescentLevel of Self-reported Communication With Son as Measured by the Parental Practicing Scale6 months follow up3.27 score on a scaleStandard Deviation 1.09
HoMBRES Diabetes Control Group - AdolescentLevel of Self-reported Communication With Son as Measured by the Parental Practicing ScaleBaseline3.36 score on a scaleStandard Deviation 0.96
HoMBRES Diabetes Control Group - AdolescentLevel of Self-reported Communication With Son as Measured by the Parental Practicing Scale6 months follow up3.47 score on a scaleStandard Deviation 1.07

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026